参考文献/References:
[1] 陈云茹,孙阳阳,邸莹,等.纤维介素2在慢性病毒性肝炎患者中的表达水平及临床意义[J].西安交通大学学报(医学版),2018,39(6):876
[2] 张伟,许荣放,田锐锋,等.阿德福韦酯与替比夫定联合恩替卡韦对失代偿期乙肝肝硬化患者肝功能及血清病毒学指标的影响[J].解放军医学杂志,2016,41(12):1041
[3] MARIOTTI V,STRAZZABOSCO M,FABRIS L,et al.Animal models of biliary injury and altered bile acid metabolism[J]. Biochim Biophys Acta Mol Basis Dis,2018,1864(4 Pt B):1254
[4] 余珈漫.血清胆碱酯酶、总胆汁酸检测在肝脏疾病诊断中的价值研究[J].中国医刊,2017,52(4):99
[5] 姜海华,王金英.血清总胆汁酸和胆碱酯酶及前白蛋白检测在肝硬化患者中的临床应用[J].中医临床研究,2017,9(7):126
[6] MA ZH,WANG XM,YIN PY,et al.Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury[J].Medicine(Baltimore),2019,98(31):e16717
[7] HORVATITS T,DROLZ A,ROEDL K,et al.Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis[J].Liver Int,2017,37(2):224
[8] LUO LA,AUBRECHT J,LI DZ,et al.Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans[J].PLoS One,2018,13(3):e0193824
[9] GOTTLIEB A,BECHMANN L,CANBAY A.The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids[J].Ann Hepatol,2018,17(3):340
[10]PURI P,DAITA K,JOYCE A,et al.The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids[J].Hepatology,2018,67(2):534
[11]LIU ZM,ZHANG ZF,HUANG M,et al.Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments[J].BMC Gastroenterol,2018,18(1):112
[12]VERBEKE L,MANNAERTS I,SCHIERWAGEN R,et al.FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis[J].Sci Rep,2016,6(1):33453
[13]ELBEL EE,LAVINE JE,DOWNES M,et al.hepatic nuclear receptor expression associates with features of histology in pediatric nonalcoholic fatty liver disease[J].Hepatol Commun,2018,2(10):1213
[14]MCGETTIGAN BM,MCMAHAN RH,LUO YH,et al.Sevelamer improves steatohepatitis, inhibits liver and intestinal farnesoid X receptor(FXR), and reverses innate immune dysregulation in a mouse model of non-alcoholic fatty liver disease[J].J Biol Chem,2016,291(44):23058
[15]WANG R,SHEPS JA,LIU L,et al.Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice[J].J Lipid Res,2019,60(1):85
[16]YU YR,LI SD,LIANG WF.Bona fide receptor for hepatitis B and D viral infections:mechanism,research models and molecular drug targets[J].Emerg Microbes Infect,2018,7(1):134
[17]ZHAO KT,LIU SH,CHEN YS,et al.Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B[J].Emerg Microbes Infect,2018,7(1):186
[18]MOUZANNAR K,FUSIL F,LACOMBE B,et al.Farnesoid X receptor-α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo[J].FASEB J,2019,33(2):2472
[19]ZENG YL,LI ZX,SHANG J,et al.Efficient delivery of HBV NLS siRNAs into HepG2.2.15 cells for HBV inhibition through novel recombinant preS1tP proteins[J].Int J Mol Med,2018,42(2):1181
[20]PASSIOURA T,WATASHI K,FUKANO K,et al.De novo macrocyclic peptide inhibitors of hepatitis b virus cellular entry[J].Cell Chem Biol,2018,25(7):906
相似文献/References:
[1]管生,李明省,马南,等.超选择性经肝动脉化疗栓塞术联合射频消融治疗严重肝硬化合并小肝癌36例[J].郑州大学学报(医学版),2010,(04):666.
[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(06):666.
[2]邹黎),毛建娜),郭长青).肝源性糖尿病80例临床分析[J].郑州大学学报(医学版),2010,(04):687.
[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(06):687.
[3]陈汇,许冰#.内皮素受体拮抗剂对肝硬化大鼠转化生长因子β1和Ⅰ型胶原mRNA表达的影响[J].郑州大学学报(医学版),2011,(05):745.
CHEN Hui,XU Bing.Effects of ET receptor antagonist on expression of TGFβ1 and collagen typeⅠmRNA in hepatic cirrhotic rats[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(06):745.
[4]苏英),郭长青),高鹏),等.HCV所致慢性肝病中肝源性糖尿病的发生率与血糖水平[J].郑州大学学报(医学版),2012,(03):422.
[5]李焱,孙长宇#,周言.非侵入性指标诊断肝硬化食管静脉曲张的价值*[J].郑州大学学报(医学版),2013,(04):505.
LI Yan,SUN Changyu,ZHOU Yan.Value of noninvasive parameters in dignosis of esophageal varices for patients with liver cirrhosis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2013,(06):505.
[6]梁丽),顾福嘉),黄国美)#,等.脐血干细胞移植治疗失代偿期肝硬化效果观察*[J].郑州大学学报(医学版),2014,(04):552.
LIANG Li,GU Fujia,HUANG Guomei,et al.Efficacy of umbilical cord blood stem cell transplantation for decompensated cirrhosis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2014,(06):552.
[7]张香梅△,杨桂林,乐晓华,等.肝细胞癌合并乙型肝炎肝硬化患者癌组织中长链非编码RNA表达谱分析*[J].郑州大学学报(医学版),2015,(02):194.
ZHANG Xiangmei,YANG Guilin,LE Xiaohua,et al.Expression profiles of long noncoding RNA in HCC patients suffering hepatitis B liver cirrhosis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2015,(06):194.